1,079 recalls tagged with “chemical hazard”.
Medline Industries recalled 104,608 units of sterile saline wound wash on January 5, 2026. The product may not have met the required sterility assurance level. Consumers should stop using this product immediately and follow recall instructions.
Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.
Wizcure Pharmaa PVT. LTD. recalled 11,520 cartons of Vista Meibo Tears Eye Drops on December 31, 2025. The recall occurred due to lack of assurance of sterility, posing a high risk to consumers. The affected product was distributed nationwide in the USA.
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Wizcure Pharmaa recalled 5,760 cartons of Vista Tears Eye Drops on December 31, 2025. The recall follows a lack of assurance of sterility in the product. Consumers should stop using the drops immediately and contact a healthcare provider for guidance.
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Medica recalled 1,578 units of its Capillary Tubes on December 31, 2025. A systematic positive bias of up to 20% can produce false elevation results in patient potassium levels. Healthcare providers and patients must stop using the device immediately.
WFM Purchasing, LP recalled 88 units of Brussel Sprouts & Kale Slaw on December 31, 2025. The product contains undeclared fish and egg allergens, posing a serious health risk. Consumers in New York, New Jersey, and Virginia should not consume this product.
BioGlo Fluorescein Sodium Ophthalmic Strips are recalled due to sterility issues. The recall affects 184,320 containers distributed nationwide in the USA. Consumers should stop using the product immediately.
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Subpotent Drug: Due oxidation caused by leakage of the contents of the Icosapent Ethyl 1g capsules. Use of the affected product may lead to inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients.
Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Potential exposure of rodents and rodent activity in the distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.